Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution.

[1]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Aifei Wang,et al.  pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. , 2011, Journal of the American Chemical Society.

[3]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[4]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[6]  Hideyoshi Harashima,et al.  A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. , 2011, Advanced drug delivery reviews.

[7]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[8]  J. Benoit,et al.  Tumor transfection after systemic injection of DNA lipid nanocapsules. , 2011, Biomaterials.

[9]  Boshi Tian,et al.  Thermo-sensitive poly(N-isopropylacrylamide)/ mesoporous silica nanocomposites as controlled delivery carriers: loading and release behaviors for drug ibuprofen. , 2011, Journal of nanoscience and nanotechnology.

[10]  Mauro Ferrari,et al.  Multi-stage delivery nano-particle systems for therapeutic applications. , 2011, Biochimica et biophysica acta.

[11]  Bernard Cabane,et al.  Protein adsorption and complement activation for di-block copolymer nanoparticles. , 2011, Biomaterials.

[12]  Yaping Li,et al.  Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. , 2011, Biomaterials.

[13]  V. S. Lin,et al.  Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules. , 2011, ACS nano.

[14]  Yaping Li,et al.  In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.

[15]  P. Couvreur,et al.  Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. , 2011, Biomacromolecules.

[16]  F. Dosio,et al.  Macromolecules as taxane delivery systems , 2011, Expert opinion on drug delivery.

[17]  Ying Song,et al.  Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. , 2010, Angewandte Chemie.

[18]  R. Cardiff,et al.  Longitudinal Investigation of Permeability and Distribution of Macromolecules in Mouse Malignant Transformation Using PET , 2010, Clinical Cancer Research.

[19]  S. Nguyen,et al.  Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy. , 2010, Journal of the American Chemical Society.

[20]  Sébastien Lecommandoux,et al.  A simple method to achieve high doxorubicin loading in biodegradable polymersomes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[21]  R. Haag,et al.  Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation , 2010, Proceedings of the National Academy of Sciences.

[22]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[23]  S Moein Moghimi,et al.  Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. , 2010, ACS nano.

[24]  M. Breunig,et al.  The mechanism of protein release from triglyceride microspheres. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[25]  P. Couvreur,et al.  Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Hainsworth,et al.  A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer. , 2010, Clinical breast cancer.

[27]  J. Bibette,et al.  Layer-by-layer surface modification of lipid nanocapsules. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  S. Nguyen,et al.  Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy. , 2010, ACS nano.

[29]  C. Haynes,et al.  The induction of thrombus generation on nanostructured neutral polymer brush surfaces. , 2010, Biomaterials.

[30]  Juan L. Vivero-Escoto,et al.  Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery , 2010, Expert opinion on drug delivery.

[31]  Hong Xu,et al.  Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. , 2010, ACS nano.

[32]  M. Thanou,et al.  Targeting nanoparticles to cancer. , 2010, Pharmacological research.

[33]  Kai Yang,et al.  Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.

[34]  Mauro Ferrari,et al.  Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.

[35]  Mary E Napier,et al.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. , 2010, Journal of the American Chemical Society.

[36]  D. Taton,et al.  pH and temperature responsive polymeric micelles and polymersomes by self-assembly of poly[2-(dimethylamino)ethyl methacrylate]-b-poly(glutamic acid) double hydrophilic block copolymers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[37]  P. Couvreur,et al.  Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. , 2010, Bioconjugate chemistry.

[38]  F. Kratz.  Albumin, a versatile carrier in oncology. , 2010, International journal of clinical pharmacology and therapeutics.

[39]  Jianing Qi,et al.  Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery. , 2010, International journal of pharmaceutics.

[40]  J. Slingerland,et al.  Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer , 2010, Breast Cancer Research and Treatment.

[41]  Mauro Ferrari,et al.  Cellular association and assembly of a multistage delivery system. , 2010, Small.

[42]  Sébastien Lecommandoux,et al.  Self-assembly of thermally responsive amphiphilic diblock copolypeptides into spherical micellar nanoparticles. , 2010, Angewandte Chemie.

[43]  Sara Linse,et al.  Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.

[44]  Yi-Hui Deng,et al.  Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes. , 2010, Biomaterials.

[45]  Jean-Luc Coll,et al.  Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  M. Neeman,et al.  Visualizing vascular permeability and lymphatic drainage using labeled serum albumin , 2010, Angiogenesis.

[47]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[48]  A. Bhatt,et al.  In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes. , 2010, Macromolecular bioscience.

[49]  J. Irache,et al.  Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. , 2010, International journal of pharmaceutics.

[50]  I. Oh,et al.  Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles. , 2010, Journal of nanoscience and nanotechnology.

[51]  Mauro Ferrari,et al.  Sustained small interfering RNA delivery by mesoporous silicon particles. , 2010, Cancer research.

[52]  R. Niu,et al.  Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery. , 2010, Biomaterials.

[53]  Mauro Ferrari,et al.  Frontiers in cancer nanomedicine: directing mass transport through biological barriers. , 2010, Trends in biotechnology.

[54]  Leaf Huang,et al.  Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  Amit Jain,et al.  The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. , 2010, Biomaterials.

[56]  Erkki Ruoslahti,et al.  Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.

[57]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[58]  S. L. Bridal,et al.  The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. , 2010, Biomaterials.

[59]  T. Mukohara,et al.  Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors , 2010, Japanese journal of clinical oncology.

[60]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[61]  Thomas Vorup-Jensen,et al.  Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation , 2010, The Journal of Immunology.

[62]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[63]  F. Hu,et al.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles , 2009, International journal of nanomedicine.

[64]  Erkki Ruoslahti,et al.  Tissue-penetrating delivery of compounds and nanoparticles into tumors. , 2009, Cancer cell.

[65]  Jean-Luc Coll,et al.  Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. , 2009, Small.

[66]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[67]  H. Horinouchi,et al.  Hemoglobin Vesicles, Polyethylene Glycol (PEG)ylated Liposomes Developed as a Red Blood Cell Substitute, Do Not Induce the Accelerated Blood Clearance Phenomenon in Mice , 2009, Drug Metabolism and Disposition.

[68]  R. Martínez‐Máñez,et al.  Controlled delivery systems using antibody-capped mesoporous nanocontainers. , 2009, Journal of the American Chemical Society.

[69]  Xenophon Papademetris,et al.  Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. , 2009, Biomaterials.

[70]  Ji-Ho Park,et al.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.

[71]  Tohru Mizushima,et al.  Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles , 2009, Pharmaceutical Research.

[72]  Valentina Cauda,et al.  Multiple core-shell functionalized colloidal mesoporous silica nanoparticles. , 2009, Journal of the American Chemical Society.

[73]  S. Nguyen,et al.  "Clickable" polymer-caged nanobins as a modular drug delivery platform. , 2009, Journal of the American Chemical Society.

[74]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[75]  Sara Linse,et al.  Complete high‐density lipoproteins in nanoparticle corona , 2009, The FEBS journal.

[76]  L. Cattel,et al.  Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. , 2009, Molecular pharmaceutics.

[77]  S. Nie,et al.  Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. , 2009, Gastroenterology.

[78]  E Froehlich,et al.  Dendrimers bind human serum albumin. , 2009, The journal of physical chemistry. B.

[79]  T. Bein,et al.  Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. , 2009, Angewandte Chemie.

[80]  Mark E. Davis.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.

[81]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[82]  J. Forrest,et al.  Influence of nanoparticle size on the pH-dependent structure of adsorbed proteins studied with quantitative localized surface plasmon spectroscopy , 2009, The European physical journal. E, Soft matter.

[83]  Alexander Kabanov,et al.  Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles , 2009, PloS one.

[84]  Jean-Christophe Leroux,et al.  Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. , 2009, Biomacromolecules.

[85]  Felix Kratz,et al.  Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[86]  Robert Langer,et al.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.

[87]  R. Harrison,et al.  Membrane ruffles capture C3bi-opsonized particles in activated macrophages. , 2008, Molecular biology of the cell.

[88]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[89]  J. A. Forrest,et al.  Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres , 2008, The European physical journal. E, Soft matter.

[90]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[91]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[92]  Rassoul Dinarvand,et al.  PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. , 2008, International journal of pharmaceutics.

[93]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[94]  S. K. Sundaram,et al.  Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[95]  Sudipta Seal,et al.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. , 2007, Biomaterials.

[96]  Sara Linse,et al.  The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. , 2007, Advances in colloid and interface science.

[97]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[98]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[99]  K. Higaki,et al.  Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. , 2007, International journal of pharmaceutics.

[100]  G. Cagney,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[101]  C. C. Landry,et al.  Diffusion-based deprotection in mesoporous materials: a strategy for differential functionalization of porous silica particles. , 2007, Journal of the American Chemical Society.

[102]  F. Kratz,et al.  Anticancer carrier-linked prodrugs in clinical trials , 2007, Expert opinion on investigational drugs.

[103]  J. Dordick,et al.  Unfolding of ribonuclease A on silica nanoparticle surfaces. , 2007, Nano letters.

[104]  G. Kenner,et al.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.

[105]  F. Kratz.  DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials , 2007, Expert opinion on investigational drugs.

[106]  Guido Bocci,et al.  Drug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification , 2007, Current oncology reports.

[107]  Xinguo Jiang,et al.  Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[108]  J. Klein.  Probing the interactions of proteins and nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[109]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[110]  Noriaki Ohuchi,et al.  In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. , 2007, Cancer research.

[111]  B. Jonsson,et al.  Induction of structure and function in a designed peptide upon adsorption on a silica nanoparticle. , 2006, Angewandte Chemie.

[112]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[113]  J. Forrest,et al.  Anomalous thermal denaturing of proteins adsorbed to nanoparticles , 2006, The European physical journal. E, Soft matter.

[114]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[115]  C. Vauthier,et al.  Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide , 2006, Pharmaceutical Research.

[116]  T. Sonobe,et al.  Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin. , 2006, International journal of pharmaceutics.

[117]  L. Diehl,et al.  CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens , 2006, Cell.

[118]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[119]  B. Jonsson,et al.  Proteolytic cleavage reveals interaction patterns between silica nanoparticles and two variants of human carbonic anhydrase. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[120]  L. Canham,et al.  Complete Tumor Response Following Intratumoral 32P BioSilicon on Human Hepatocellular and Pancreatic Carcinoma Xenografts in Nude Mice , 2005, Clinical Cancer Research.

[121]  R. Müller,et al.  Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.

[122]  Bengt-Harald Jonsson,et al.  Transient interaction with nanoparticles "freezes" a protein in an ensemble of metastable near-native conformations. , 2005, Biochemistry.

[123]  R. Müller,et al.  Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. , 2005, Biomaterials.

[124]  R. Müller,et al.  Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[125]  Xin Yu Wang,et al.  Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[126]  R. Müller,et al.  Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.

[127]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[128]  J. Behr,et al.  Genuine DNA/polyethylenimine (PEI) Complexes Improve Transfection Properties and Cell Survival , 2004, Journal of drug targeting.

[129]  T. Ishida,et al.  Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[130]  Rainer H Müller,et al.  Functional groups on polystyrene model nanoparticles: influence on protein adsorption. , 2003, Journal of biomedical materials research. Part A.

[131]  R. Müller,et al.  Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. , 2003, Journal of drug targeting.

[132]  Jun Fang,et al.  Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. , 2003, International immunopharmacology.

[133]  Masahiro Fujiwara,et al.  Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.

[134]  R. Müller,et al.  Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[135]  S. Davis,et al.  The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.

[136]  R. Jain,et al.  Oncotic pressure in solid tumors is elevated. , 2000, Cancer research.

[137]  R. Müller,et al.  Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.

[138]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[139]  M. Lück,et al.  Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis. , 1999, Biomaterials.

[140]  J. Behr,et al.  Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody‐derivatized polyethylenimines (PEI) , 1999, The journal of gene medicine.

[141]  M. Lück,et al.  Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.

[142]  L. Balant,et al.  Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. , 1997, Journal of biomedical materials research.

[143]  S. Hirota,et al.  Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. , 1996, Biochimica et biophysica acta.

[144]  G. Borchard,et al.  The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (methyl methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement , 1996, Pharmaceutical Research.

[145]  R. Gurny,et al.  An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.

[146]  Dexi Liu,et al.  Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. , 1995, Biochimica et biophysica acta.

[147]  W. Norde,et al.  Influence of PEGylation with linear and branched PEG chains on the adsorption of glucagon to hydrophobic surfaces. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[148]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[149]  S. Rowan,et al.  Using the dynamic bond to access macroscopically responsive structurally dynamic polymers. , 2011, Nature materials.

[150]  Mauro Ferrari,et al.  An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. , 2010, Advances in genetics.

[151]  Hak Soo Choi,et al.  Design considerations for tumour-targeted nanoparticles. , 2010, Nature nanotechnology.

[152]  J. Benoit,et al.  Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. , 2010, Biomaterials.

[153]  Andrew D. Miller,et al.  Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles. , 2009, Bioconjugate chemistry.

[154]  J. Benoit,et al.  Positively-Charged, Porous, Polysaccharide Nanoparticles Loaded with Anionic Molecules Behave as ‘Stealth’ Cationic Nanocarriers , 2009, Pharmaceutical Research.

[155]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[156]  R. Müller,et al.  Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. , 2006, Biomaterials.

[157]  H. Maeda,et al.  Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. , 2003, Advances in experimental medicine and biology.